Environmental and programmed regulation of start codon recognition

起始密码子识别的环境和程序调控

基本信息

  • 批准号:
    8825713
  • 负责人:
  • 金额:
    $ 19.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-13 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Abstract: Changes in environmental conditions can affect gene expression at many levels. In general, alterations in transcription have been the most widely explored consequences of environmental perturbations, but changes at the level of the translation of specific mRNAs can also have profound effects on a cell's ability to respond to environmental stresses and to damage caused by toxins or other external agents. In addition, execution of critical genetic programs that determine a cell's fate and function - including many developmental processes - frequently begins at the translational level. Disregulation of the initiation phase of protein synthesis plays a role in the etiology of a variety of human diseases, from cancers to neurodegenerative disorders. The selection of the start codon in an mRNA by the translational machinery is a critical phase of gene expression because it determines both the N-terminus of the protein that will be produced and the reading frame of decoding. There is considerable circumstantial evidence that the fidelity of start codon recognition can be affected by environmental conditions - for example, exposure to stressors and toxins or changes in the levels of specific nutrients - and that these changes alter gene expression in ways that affect the physiology of the cell. Changes in the fidelity of start codon recognition could result in production of protein isoforms with different N-termini created by translation initiation from alternative start codons in the 5'-leaders of mRNAs. It could also change expression levels of proteins by modulating translation of regulatory upstream open reading frames in mRNAs. These alterations in gene expression could be harmful to the cell, if unprogramed, or beneficial, if they are part of a posttranscriptional gene regulatory mechanism that allows the cell to respond to its altered environment or internal or external signals. Using an established, high-throughput dual-luciferase assay for measuring the fidelity of start codon recognition we will: 1) Test the hypothesis that external conditions, signals and internal cues can modulate the fidelity of start codon recognition to alter gene expression at the translational level; 2) Determine the effects of forcing changes in the fidelity of start codon recognition on cell physiology and gene expression. These studies have the potential to uncover a completely new mode of post-transcriptional gene regulation. They will also provide important insights into how environmental conditions affect gene expression at the translational level, as well as the consequences of these changes for cell physiology.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS T INGOLIA其他文献

NICHOLAS T INGOLIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS T INGOLIA', 18)}}的其他基金

Diverse and dynamically regulated mRNP composition regulating translation
多样化且动态调节的 mRNP 组成调节翻译
  • 批准号:
    10595228
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Post-translational phenotypic profiling through nucleotide barcode sequencing
通过核苷酸条形码测序进行翻译后表型分析
  • 批准号:
    10649344
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
High-precision pooled screening for quantitative molecular phenotypes
定量分子表型的高精度联合筛选
  • 批准号:
    10462811
  • 财政年份:
    2020
  • 资助金额:
    $ 19.56万
  • 项目类别:
High-precision pooled screening for quantitative molecular phenotypes
定量分子表型的高精度联合筛选
  • 批准号:
    10058222
  • 财政年份:
    2020
  • 资助金额:
    $ 19.56万
  • 项目类别:
High-precision pooled screening for quantitative molecular phenotypes
定量分子表型的高精度联合筛选
  • 批准号:
    10245276
  • 财政年份:
    2020
  • 资助金额:
    $ 19.56万
  • 项目类别:
High-precision pooled screening for quantitative molecular phenotypes
定量分子表型的高精度联合筛选
  • 批准号:
    10684783
  • 财政年份:
    2020
  • 资助金额:
    $ 19.56万
  • 项目类别:
Functional genomics of the dynamic molecular network controlling mRNA translation and decay
控制 mRNA 翻译和衰变的动态分子网络的功能基因组学
  • 批准号:
    10357812
  • 财政年份:
    2019
  • 资助金额:
    $ 19.56万
  • 项目类别:
Profiling activity-dependent synaptic translation
分析活动依赖性突触翻译
  • 批准号:
    9806853
  • 财政年份:
    2019
  • 资助金额:
    $ 19.56万
  • 项目类别:
Functional genomics of the dynamic molecular network controlling mRNA translation and decay
控制 mRNA 翻译和衰变的动态分子网络的功能基因组学
  • 批准号:
    10116424
  • 财政年份:
    2019
  • 资助金额:
    $ 19.56万
  • 项目类别:
Molecular Basis and Cellular Roles of Translational Regulation
翻译调控的分子基础和细胞作用
  • 批准号:
    8755583
  • 财政年份:
    2014
  • 资助金额:
    $ 19.56万
  • 项目类别:

相似国自然基金

流感病毒感染T淋巴细胞并致感染细胞异常死亡机制研究
  • 批准号:
    81970010
  • 批准年份:
    2019
  • 资助金额:
    56.0 万元
  • 项目类别:
    面上项目
程序性细胞死亡分子5的免疫负向调节作用以及分子机制研究
  • 批准号:
    31370898
  • 批准年份:
    2013
  • 资助金额:
    90.0 万元
  • 项目类别:
    面上项目

相似海外基金

Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 19.56万
  • 项目类别:
UBR5's mechanisms of action in tumorigenesis and immunoregulation
UBR5在肿瘤发生和免疫调节中的作用机制
  • 批准号:
    10659844
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
调节PD-1/PD-L1检查点促进肉瘤患者HER2 CAR T细胞的抗肿瘤活性
  • 批准号:
    10562836
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
识别和靶向非小细胞肺癌化疗引起的免疫治疗耐药的新机制
  • 批准号:
    10657188
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Full Project 2
完整项目2
  • 批准号:
    10762291
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Endocrine tissue molecular pathways dysregulated by immune checkpoint inhibitors causing ICI-triggered adverse events
免疫检查点抑制剂导致内分泌组织分子通路失调,导致 ICI 引发的不良事件
  • 批准号:
    10648465
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Fatty Acid Metabolic Regulation of Anti-Tumor Immunity Against Irradiated Glioblastoma
脂肪酸代谢调节抗辐射胶质母细胞瘤的免疫
  • 批准号:
    10638744
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Mechanisms of REST-mediated immunosuppression in cancer
REST 介导的癌症免疫抑制机制
  • 批准号:
    10749289
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
“Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”
– NR4A1 和 NR4A2 的药理学靶向激活胶质母细胞瘤治疗反应 –
  • 批准号:
    10744524
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
纳米免疫药物靶向肿瘤微环境治疗神经胶质瘤
  • 批准号:
    10743942
  • 财政年份:
    2023
  • 资助金额:
    $ 19.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了